Cellceutix Arranges $1 Million Financing for Clinical Trials of New Cancer Drug; IND Filing Imminent

BEVERLY, MA -- (Marketwire) -- 05/14/12 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a biopharmaceutical company…

Continue Reading

Cellceutix CEO Leo Ehrlich Interviewed by TheStreetBeat.com

CEO Discusses Company Pipeline and Connections With Dana-Farber, Pfizer and Beth Israel Deaconess Medical Center

Continue Reading